**HPA axis response**

The hypothalamic‑pituitary‑adrenal (HPA) axis is the primary neuroendocrine circuit that coordinates the organism’s reaction to stress. Activation initiates a hormonal cascade—CRH → ACTH → glucocorticoids—that modulates metabolism, immunity, and behavior. Dysregulation of this axis contributes to a range of psychiatric and metabolic disorders.

---

## 2. Location & Context
- **Sites**: paraventricular nucleus (PVN) of the hypothalamus, anterior pituitary corticotrophs, zona fasciculata of the adrenal cortex.  
- **Baseline activity**: present in all mammals; regulated by afferent neural, hormonal, and circadian inputs.

## 3. Classification & Structure
- **Type**: neuroendocrine signaling pathway.  
- **Components**: neuropeptide (CRH), peptide hormone (ACTH), steroid hormone (cortisol/ corticosterone).

## 4. Physiological / Biological Function
- **Stress mobilization**: increases glucose availability, suppresses non‑essential functions (e.g., reproduction).  
- **Circadian regulation**: maintains diurnal cortisol rhythms.  
- **Feedback**: glucocorticoids inhibit CRH and ACTH release (negative feedback).

## 5. Receptor Binding & Signaling
- **CRH** binds to `CRHR1` on pituitary corticotrophs → Gs‑protein → PKA activation → ACTH synthesis.  
- **ACTH** binds to `MC2R` on adrenal cortex → adenylate cyclase → cAMP → steroidogenic acute regulatory protein (StAR) activation → cortisol production.  
- **Glucocorticoids** bind to the glucocorticoid receptor (`GR`, encoded by `NR3C1`) → nuclear translocation → gene transcription modulation (genomic) and rapid membrane actions (non‑genomic).

## 6. Tissue‑Specific Actions
| Target | Effect |
|--------|--------|
| Brain | Modulates anxiety, fear learning, and circadian gating of behavior |
| Liver | Promotes gluconeogenesis and glycogenolysis |
| Adipose | Induces lipolysis and fat redistribution |
| Immune cells | Suppresses pro‑inflammatory cytokine production |

## 7. Interaction with Other Biomolecules
- **Neurotransmitters**: vasopressin augments CRH; norepinephrine enhances ACTH release.  
- **Cytokines**: IL‑6, TNF‑α stimulate CRH transcription.  
- **Clock genes**: `CLOCK`, `BMAL1` regulate circadian HPA output.

## 8. Genetic Polymorphisms & Variants
- SNPs in `CRHR1` and `NR3C1` alter stress reactivity and glucocorticoid sensitivity.  
- Variants in `FKBP5` affect GR co‑factor function, linked to depression and PTSD susceptibility.

## 9. Dietary & Environmental Influences
- Chronic stress, sleep loss, and high‑fat diets elevate basal cortisol.  
- Estrogen increases cortisol‑binding globulin, raising total cortisol levels.  
- Physical activity reduces HPA axis reactivity.

## 10. Pathophysiological Associations
- **Hypercortisolism**: Cushing’s syndrome, chronic stress → metabolic syndrome, osteoporosis.  
- **Hypocortisolism**: Addison’s disease → fatigue, hyperpigmentation.  
- **Psychiatric disorders**: depression, anxiety, PTSD, bipolar disorder.  
- **Metabolic conditions**: insulin resistance, obesity.

## Optional Sections

### Clinical Biomarkers
- Serum/plasma `ACTH` and `cortisol`.  
- Salivary cortisol for diurnal rhythm assessment.  
- Dexamethasone suppression test for feedback integrity.

### Therapeutic Relevance
- **CRH antagonists** (e.g., pexacerfont) for anxiety.  
- **Glucocorticoid receptor modulators** (e.g., mifepristone).  
- **Steroidogenesis inhibitors** (e.g., metyrapone, ketoconazole) for Cushing’s.  
- **Adjunctive therapy**: psychotherapy, exercise, sleep hygiene to normalize HPA tone.

### Molecular Pathways
- `CRH → CRHR1 → Gs → PKA → ACTH synthesis`.  
- `ACTH → MC2R → Gs → cAMP → StAR → steroidogenesis`.  
- `Cortisol → GR → transcriptional regulation + non‑genomic actions`.  
- Negative feedback via `GR` repression of `CRH` and `ACTH` genes.